Replimune | BiotechTV

top of page

Jun 10

Replimune's CEO discusses last week's PD-1 refractory melanoma data and the company's plans to file for accelerated approval

Sushil Patel describes Replimune's ASCO and follow-on data from last week in the context of PD-1 response rates and competitor data from...

Jun 3, 2023

Company News

Modality profile: Oncolytic Immunotherapies at #ASCO23

Replimune Founder and Head of R&D Robert Coffin describes the oncolytic immunotherapy approach to cancer research.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh